|
Research Management and Support
|
RMS ES 2018
|
$340,640,887
|
$541,000
|
N/A
|
National Institutes of Health
|
|
Origins of BRAF-mutant hematologic malignancies and their therapeutic resistance
|
5R01CA201247-03
|
$511,614
|
$511,614
|
ABDEL-WAHAB, OMAR
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Sphingolipid Signaling in Mammals
|
ZIA BC 011187
|
$679,649
|
$679,649
|
Acharya, Jairaj
|
CCR (NCI)
|
|
Nanoparticle mediated microenvironmental targeting of CCL3 signaling for the treatment of acute myelogenous leukemia
|
1F31CA228391-01
|
$42,418
|
$42,418
|
ACKUN-FARMMER, MARIAN
|
UNIVERSITY OF ROCHESTER
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-05S1
|
$2,256,906
|
$756,064
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-05
|
$20,853,800
|
$6,986,023
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Probing the role of the IRE1alpha-XBP1 pathway in normal and malignant hematopoiesis
|
5K22CA218467-02
|
$192,575
|
$192,575
|
ADORO, STANLEY
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
3U10CA180791-04S1
|
$145,357
|
$5,814
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-05
|
$922,200
|
$36,888
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
SON-mediated gene expression and leukemia
|
5R01CA190688-03
|
$346,556
|
$346,556
|
AHN, ERIN
|
UNIVERSITY OF SOUTH ALABAMA
|
|
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia.
|
5R01CA133379-10
|
$381,375
|
$381,375
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Genetic Dissection of Acute Myeloid Leukemia.
|
5R01CA169784-05
|
$355,993
|
$355,993
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Long non-coding RNAs in hematopoiesis and blood malignancy
|
5R01CA194923-04
|
$457,533
|
$457,533
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Mapping cancer micro-environments for acute leukemia
|
5R01CA202025-03
|
$455,870
|
$455,870
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
The cohesin complex as a tumor suppressor in myeloid leukemia
|
5R01CA216421-02
|
$511,640
|
$511,640
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Dr. Keiko Akagi, A Bioinformatics Specialist in Cancer Genomics Research at OSU Comprehensive Cancer Center
|
5R50CA211533-03
|
$122,475
|
$122,475
|
AKAGI, KEIKO
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
ATBC Study
|
ZIA CP010195 03031
|
$738,165
|
$22,145
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Site
|
5U10CA180790-05
|
$1,223,634
|
$48,945
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
Functional and Mechanistic Study of Histone Crotonylation in Hematological Malignancies
|
5R01CA204639-03
|
$698,696
|
$698,696
|
ALLIS, CHARLES
|
ROCKEFELLER UNIVERSITY
|
|
Therapeutic resistance in leukemic cells: targeting BCL-2 family and autophagy
|
5R01CA184137-04
|
$362,569
|
$362,569
|
ALMASAN, ALEXANDRU
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144 07130
|
$1,652,758
|
$528,883
|
Alter, Blanche
|
DCEG (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$753,084
|
$37,654
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
The regulation of dendritic cell function by LMYC at steady state and during immune responses to cancer
|
1F31CA228240-01
|
$30,442
|
$7,611
|
ANDERSON, DAVID
|
WASHINGTON UNIVERSITY
|
|
Molecular Studies of Cellular Cytotoxicity
|
ZIA BC 010013
|
$755,862
|
$755,862
|
Anderson, Stephen
|
CCR (NCI)
|
|
Collaborative Pathways that Lead to Leukemia
|
ZIA BC 010982
|
$437,122
|
$437,122
|
Aplan, Peter
|
CCR (NCI)
|
|
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
|
ZIA BC 010983
|
$374,676
|
$374,676
|
Aplan, Peter
|
CCR (NCI)
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$374,676
|
$187,338
|
Aplan, Peter
|
CCR (NCI)
|
|
Mechanisms of Chromosomal Translocation
|
ZIA SC 010379
|
$62,446
|
$31,223
|
Aplan, Peter
|
CCR (NCI)
|
|
Adult Leukemia Research Center
|
2P01CA018029-42A1
|
$3,990,001
|
$2,713,201
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-05
|
$605,293
|
$30,265
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
COMPRENDO: Adaptation and Implementation of a Peer-Navigation Intervention to Improve Research Literacy and Diversity in Pediatric Leukemia Clinical Trials
|
1K08CA230306-01
|
$254,821
|
$254,821
|
ARISTIZABAL, PAULA
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell Immunotherapy
|
5R01CA201225-03
|
$490,809
|
$490,809
|
ARMISTEAD, PAUL
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Targeting DOT1L for Degradation in MLL-rearranged Leukemia
|
2R01CA176745-07
|
$404,076
|
$404,076
|
ARMSTRONG, SCOTT
|
DANA-FARBER CANCER INST
|
|
Childhood Cancer Survivor Study
|
3U24CA055727-24S1
|
$120,439
|
$24,088
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Research Training in Pediatric Oncology
|
5T32CA136432-10
|
$491,462
|
$491,462
|
ARMSTRONG, SCOTT
|
DANA-FARBER CANCER INST
|
|
Childhood Cancer Survivor Study
|
5U24CA055727-24
|
$4,218,764
|
$843,753
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Stanford Cancer Institute
|
3P30CA124435-11S1
|
$248,520
|
$9,941
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Stanford Cancer Institute
|
3P30CA124435-11S2
|
$171,518
|
$6,861
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Stanford Cancer Institute
|
5P30CA124435-11
|
$3,334,464
|
$133,379
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
3P30CA142543-09S1
|
$249,371
|
$2,494
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
5P30CA142543-09
|
$2,480,000
|
$24,800
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant
|
2P30CA082103-19
|
$7,954,381
|
$636,350
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S1
|
$84,000
|
$6,720
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S2
|
$206,488
|
$16,519
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S3
|
$257,838
|
$20,627
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Stopping Tyrosine Kinase Inhibitors in CML Patients (Stop-TKIs)
|
5R01CA184798-05
|
$620,114
|
$620,114
|
ATALLAH, EHAB
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Personalized vaccine for patients with AML
|
5R01CA212649-02
|
$721,179
|
$721,179
|
AVIGAN, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Mechanism of non-oncogene addiction
|
1R01CA211594-01A1
|
$363,713
|
$363,713
|
AZAM, MOHAMMAD
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Integrative framework for identifying dysregulated mechanisms in the tumor-immune microenvironment
|
1K99CA230195-01
|
$134,632
|
$134,632
|
AZIZI, ELHAM
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$91,803
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
Total relevant funding to Leukemia for this search: $258,284,568
|